AI has moved beyond experimentation. Across biopharma, the question is no longer if AI can deliver value but where and how is value being delivered, how to deploy it at scale and embed it into core business and R&D workflows.
The PharmAI Leaders Exchange brings together 30 senior decision makers for delivering measurable returns from AI investments. Through candid, closed-door discussions, participants will share practical lessons on moving beyond pilots and proof-of-concept initiatives toward enterprise deployment, robust governance, and sustained performance.